Craig Parker

Craig Parker is a Board Member at InduPro and serves as a Venture Partner at The Column Group.14 He brings extensive experience in the biopharmaceutical industry, with over 25 years in science and business leadership roles.1

Professional Background

Currently, Parker is the CEO and President of Surrozen, a position he has held since March 2018.2 At Surrozen, he leads the company's efforts in discovering and developing novel regenerative medicines focused on the Wnt signaling pathway.3

Previous Experience

Parker's career includes several notable positions:

• Senior Vice President of Corporate Development at Jazz Pharmaceuticals (2014-2018)3
• Executive Vice President of Corporate Development & Scientific Affairs at Geron Corporation (2012-2014)3
• Senior Vice President of Strategy and Corporate Development at Human Genome Sciences (2011-2012)3
• Co-Founder and CEO of Vega Therapeutics (2009-2011)3
• Managing Director at Lehman Brothers (2002-2007)3

Education

Parker holds an MBA from the University of Michigan's Stephen M. Ross School of Business and a bachelor's degree in biology from the University of Chicago.3 He also attended the Georgetown University School of Medicine.3

Additional Roles

In addition to his board position at InduPro, Parker serves on the Scientific Advisory Board of the Life Sciences Institute at the University of Michigan and chairs the institute's Leadership Council.13

Craig Parker's diverse experience in both scientific and business aspects of the biopharmaceutical industry makes him a valuable asset to InduPro's board of directors.